drugset / Trial / NCT02938182

Migraine Prophylaxis With Clopidogrel Trial

NCT02938182 ↗

NaSingle-groupOpen-labelTreatment

Summary

The underlying mechanisms of association between the right-to-left shunts (RLS) and migraine may concern with platelet aggregation and paradoxical embolization. The aim of the study is to evaluate the prophylactic effectiveness of clopidogrel for migraineurs with RLS.

Timeline

Start
2016-10
Primary completion
2023-10
Completion
2023-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Clopidogrel Small molecule 75 mg —

Indications